De Backer Marianne insider trades
De Backer Marianne has filed 17 Form 4s with the SEC that we hold, for Vir Biotechnology, Inc. (VIR) (President and CEO, Director), KRON (Director) and Arrowhead Pharmaceuticals, INC. (ARWR) (Director). Across all of them we count 3 purchases worth $32.9K and 9 sales worth $2.6M reported on Form 4. In the last 12 months: 0 purchases ($0) and 3 sales ($947.2K). The largest single trade was a sale of 72,995 shares of Vir Biotechnology, Inc. worth $690.5K, dated 2024-04-03. The first filing on our record is dated 2021-08-24 and the latest 2026-04-30.
Vir Biotechnology, Inc. (VIR)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2024-04-03 | S, sale reported on Form 4 | 72,995 | $690.5K | 2024-04-04 | SEC |
| 2025-02-24 | S, sale reported on Form 4 | 16,122 | $152.4K | 2025-02-25 | SEC |
| 2025-04-03 | S, sale reported on Form 4 | 79,712 | $474.3K | 2025-04-04 | SEC |
| 2026-02-23 | S, sale reported on Form 4 | 19,039 | $141.8K | 2026-02-24 | SEC |
| 2026-02-24 | S, sale reported on Form 4 | 14,762 | $140.7K | 2026-02-26 | SEC |
| 2026-04-06 | S, sale reported on Form 4 | 72,559 | $664.6K | 2026-04-07 | SEC |
KRON
Arrowhead Pharmaceuticals, INC. (ARWR)
Counted from the Form 4 filings this reporting owner (SEC CIK 1797819) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
